Psychotropic Medications And Developmental Disabilities

Do you know... How to detect adverse side effects in a nonverbal person? What particular drugs might interfere with a child's learning? What potentially harmful drug interactions have been documented? How standard dosage levels differ for a person with mental retardation and a dual diagnosis? 25% to 50% of adults with developmental disabilities take psychotropic medications on a daily basis. But do you know the real impact these drugs have? Find out in this essential reference, where you'll learn about - diagnosis of disabilities - pharmacology - side effects - drug interactions - best practices - more than 430 drug names, functional categories, and generic/brand names Based on real, practical knowledge, this impressive volume is the product of 6 years of work from more than 100 physicians and other professionals from 7 disciplines--neurology, nursing, pharmacy, pediatrics, psychiatry, psychology, and special education--as well as consumers and families. It's a truly comprehensive resource you'll use to work safely and skillfully with individuals who have developmental disabilities!

Psychopharmacology of the Developmental Disabilities explores the use of psychotropic and antiepileptic medications in developmentally disabled patients. A distinguished group of international experts offers comprehensive coverage of traditional psychotropic as well as novel pharmacological agents, antiepileptic drugs, and diet and vitamin treatments. Issues related to litigation, measurement of blood levels, tardive dyskinesia, and behavioral pharmacology are discussed in detail. Psychopharmacology of the Developmental Disabilities provides an excellent overview of what is known about psychoactive drugs and an awareness of the principal social and medical issues posed by these agents.

Patients with intellectual disability (ID) can benefit from the full range of mental health services. To ensure that psychiatric assessment, diagnosis and treatment interventions are relevant and effective; individuals with ID should be evaluated and treated within the context of their developmental framework. Behavior should be viewed as a form of communication. Individuals with ID often present with behavioral symptoms complicated by limited expressive language skills and undiagnosed medical conditions. Many training programs do not include focused study of individuals with ID, despite the fact that patients with ID will be seen by virtually every mental health practitioner. In this book, the authors present a framework for competent assessment and treatment of psychiatric disorders in individuals with ID. Psychiatry of Intellectual Disability is a resource guide for psychiatrists, nurse practitioners, and other prescribers treating patients with ID. It is a supplemental text for psychiatry residents, medical students, psychology graduate students, psychotherapists, counselors, social workers, behavior support specialists and nurses. To assist the practicing clinician the book includes: Clinical vignettes Clinical pearls Charts for quick reference Issues concerning medications and poly-pharmacy Altered diagnostic criteria specific for use with individuals with ID There are no evidence-based principles dedicated to psychotropic medication use in ID, but consensus guidelines address the high prevalence of poly-pharmacy. Altered diagnostic criteria have been published which accommodate less self-report and incorporate collateral information; this book reviews the literature on psychotropic medications, consensus guidelines, and population-specific diagnostic criteria sets. Psychiatry of Intellectual Disability also includes: Interviewing techniques and assessment tips for all levels of communicative ability as well as for nonverbal individuals Assessment of aggression to determine etiology and formulate a treatment plan Overview of types of psychotherapy and suggested alterations for each to increase efficacy Relevant legal issues for caregivers and treatment providers The detective work involved in mental health assessment of individuals with ID is challenging yet rewarding. The highest quality mental health treatment limits hospital days, improves quality of life and often allows individuals to live in the least restrictive environments. Psychiatry of Intellectual Disability is a must have resource for clinicians treating the ID population.

The authors provide thorough coverage of current psychotropic medications and pharmacologic practices used in nursing care. It examines psychotropic drug use, drugs used in treatment of medical disorders, drug issues related to psychopharmacology, and developmental issues related to psychotropic drugs. More than 90 drugs are profiled.

In this book the current principles of clinical practice in assessment, management, and services for individuals with developmental disabilities (DD) and mental retardation (MR) are covered. Written and edited by experts in the field, this is a useful addition in the understanding and treatment of these patients. the purpose is to provide a comprehensive review of all the aspects of the psychiatric and behavioral disorders in DD and MR. the editor has met this goal with an excellent volume. the intended audience is clinicians, including psychiatrists, neurologists, pediatricians, primary care

This handbook presents a diverse range of effective treatment approaches for individuals with intellectual and developmental disabilities (IDD). Its triple focus on key concepts, treatment and training modalities, and evidence-based interventions for challenging behaviors of individuals with IDD provides a solid foundation for effective treatment strategies, theory-to-implementation issues, and the philosophical and moral aspects of care. Expert contributions advocate for changes in treating individuals with intellectual and developmental disabilities by emphasizing caregiver support as well as respecting and encouraging client autonomy, self-determination, and choice. With its quality-of-life approach, the handbook details practices that are person-centered and supportive as well as therapeutically sound. Topics featured in the handbook include: Functional and preference assessments for clinical decision making. Treatment modalities from cognitive behavioral therapy and pharmacotherapy to mindfulness, telehealth, and assistive technologies. Self-determination and choice as well as community living skills. Quality-of-life issues for individuals with IDD. Early intensive behavior interventions for autism spectrum disorder. Skills training for parents of children with IDD as well as staff training in positive behavior support. Evidence-based interventions for a wide range of challenging behaviors and issues. The Handbook of Evidence-Based Practices in Intellectual and Developmental Disabilities is a must-have resource for researchers, clinicians, scientist-practitioners, and graduate students in clinical psychology, social work, behavior therapy, and rehabilitation.

The third edition of this book provides cutting-edge research on psychiatry and intellectual disability, from genetics to service delivery.